Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor

    Kidney International Reports Date published:

  • Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program

    American Journal of Kidney Diseases Date published:

  • Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease

    Clinical Pharmacology & Therapeutics Date published:

  • Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial

    Date published:

  • Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial

    Date published:

  • ASCEND-ND: STUDY DESIGN AND BASELINE CHARACTERISTICS

    Date published:

  • IL-6 Inhibitor Ziltivekimab Increases Serum Hemoglobin and Iron Biomarkers in Patients with CKD Stage 3-5: A RESCUE Trial Analysis

    Date published:

  • ASCEND Program: Efficacy and Safety from ASCEND-D and -ND and Overall MACE Finding

    Date published:

  • Circulating Metabolites to Predict Renal Outcomes in CANVAS Type 2 Diabetes Mellitus Population

    Date published:

  • The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Trial

    Date published:

  • The TESTING Study: Steroids vs. Placebo in High Risk IgA Nephropathy

    Date published:

  • Effects of Canagliflozin (CANA) on Kidney Outcomes: Pooled Analyses from the CANVAS Program and CREDENCE

    Date published:

  • Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial

    Clinical Kidney Journal Date published:

  • Forever Starts Now

    Clinical Journal of the American Society of Nephrology Date published:

  • The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes

    Diabetes, Obesity and Metabolism Date published:

  • Availability, coverage, and scope of health information systems for kidney care across world countries and regions

    Nephrology Dialysis Transplantation Date published: